Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue

This publication has 14 references indexed in Scilit:

• DOES RENEWED SEXUAL ACTIVITY INCREASE CARDIAC MORBIDITY? META-ANALYSIS OF THE EXPERIENCE WITH MUSE [R] (ALPROSTADIL)
  Journal of Urology, 1999
• SILDENAFIL, A TYPE-5 CGMP PHOSPHODIESTERASE INHIBITOR, SPECIFICALLY AMPLIFIES ENDOGENOUS cGMP-DEPENDENT RELAXATION IN RABBIT CORPUS CAVERNOSUM SMOOTH MUSCLE IN VITRO
  Journal of Urology, 1998
• Oral Sildenafil in the Treatment of Erectile Dysfunction
  New England Journal of Medicine, 1998
• Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
  New England Journal of Medicine, 1991
• Intravenous milrinone: Therapeutic responses in heart failure
  American Heart Journal, 1991
• Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes
  Trends in Pharmacological Sciences, 1991
• Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle
  European Journal of Pharmacology, 1990
• Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility.
  Circulation Research, 1987
• Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure
  Journal of Medicinal Chemistry, 1984
• Purification of two calcium/calmodulin-dependent forms of cyclic nucleotide phosphodiesterase by using conformation-specific monoclonal antibody chromatography
  Proceedings of the National Academy of Sciences, 1982